Follow the Nuwellis, Inc. share price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Market capitalisation: €160k. The latest transaction was filed on 11 June 2025 (C). Among the most active insiders: ERB JOHN L. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Nuwellis, Inc. is a company focused on developing innovative medical solutions for the treatment of edema. It is listed on the NASDAQ under the ticker symbol NUWE.